|Systematic (IUPAC) name|
|ATC code||R07AB04 (WHO)|
|Molar mass||223.268 g/mol[[Script error: No such module "String".]]|
Etamivan (INN) or ethamivan (USAN), trade name Analepticon, is a respiratory stimulant drug related to nikethamide. It was mainly used in the treatment of barbiturate overdose and chronic obstructive pulmonary disease, but has now largely fallen into disuse.
Cite error: Invalid
parameter "group" is allowed only.
<references />, or
<references group="..." />
|45px||This drug article relating to the respiratory system is a stub. You can help ssf by expanding it.|
- Hirsh K, Wang SC. Respiratory stimulant effects of ethamivan and picrotoxin. Journal of Pharmacology and Experimental Therapeutics. 1975 May;193(2):657-63.
- Wheeldon PJ, Perry AW. The use of ethamivan in the treatment of barbiturate poisoning. Canadian Medical Association Journal. 1963 Jul 6;89:20-2.
- Sproule BJ, Jans RL, Breitkreutz H, Mahon W. Effects of ethamivan in patients with chronic respiratory disease. Canadian Medical Association Journal. 1964 Dec 5;91:1203-8.